Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.31
Shares Outstanding179.5M
Average Volume (10 days)1.0M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.62)
Sales (TTM)$8.40
Book Value (MRQ)$16.50
Cash Flow (TTM)$0.10
Cash (MRQ)$4.08

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy11
 
Buy1
 
Hold2
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Elizabeth McKee Anderson
4,490
Acquire
Jul 9, 2019
V. Bryan Lawlis
(3,750)
Sell
Jun 17, 2019
G. Eric Davis
SVP, General Counsel
300
Dispose
Jun 5, 2019
Robert A. Baffi
EVP, Technical Operations
14,160
Acquire
Jun 5, 2019
Jeff Ajer
SVP, Chief Commercial Of
14,160
Acquire
Jun 5, 2019

Recent SEC Filings

Insider Buy/Sell
Aug 8, 2019
Quarterly Financials
Aug 2, 2019
Company Events
Aug 1, 2019
Insider Buy/Sell
Jul 12, 2019
Insider Buy/Sell
Jul 11, 2019

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information